default author photo

Bruce Pawel

Children's Hospital Los Angeles - Department of Pathology and Laboratory Medicine

United States

University of Southern California - Keck School of Medicine

Los Angeles, CA 90089

United States

SCHOLARLY PAPERS

1

DOWNLOADS

69

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

The D3-GPC2-PBD ADC is Potently Efficacious Against Neuroblastoma and SCLC Via Engagement of a Conformational GPC2 Epitope

Number of pages: 86 Posted: 18 Sep 2020
Hospital for Sick Children Research Institute - Program in Molecular Medicine, Children’s Hospital of Philadelphia - Division of Oncology, Children’s Hospital of Philadelphia - Division of Oncology, University of Pittsburgh - Department of Medicine, National Cancer Institute - Cancer and Inflammation Program, Hospital for Sick Children Research Institute - Program in Molecular Medicine, University of Pennsylvania - Department of Pathology and Lab Medicine, Children's Hospital of Philadelphia - Department of Pathology, National Cancer Institute - Cancer and Inflammation Program, Children's Hospital of Philadelphia - Division of Oncology, Children's Hospital of Philadelphia - Department of Bioinformatics and Health Informatics, University of Pennsylvania - The Center for Data Driven Discovery in Biomedicine, Integral Molecular, Integral Molecular, Children's Hospital Los Angeles - Department of Pathology and Laboratory Medicine, University of Pittsburgh - Department of Medicine, Children’s Hospital of Philadelphia - Division of Oncology, Hospital for Sick Children Research Institute - Program in Molecular Medicine and Children’s Hospital of Philadelphia - Division of Oncology
Downloads 69 (883,195)

Abstract:

Loading...

Glypican, neuroblastoma, small-cell lung cancer, antibody-drug conjugate, MYCN